Cite

HARVARD Citation

    Janjetovic, S. et al. (2019). Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib. Tumori. 105 (6), pp. NP8-NP11. [Online]. 
  
Back to record